Business Context and Reporting Period
Company: Construction Partners, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 6, 2026 (Earliest event reported)
Reporting Period: Events occurring between August 6, 2026, and August 10, 2026.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses on corporate governance and equity issuance events.
Material Changes and Events
- Board Composition Change: The Audit Committee was reduced to two independent directors following the death of Michael H. McKay, an independent director and Audit Committee member.
- Nasdaq Compliance Status: The Company is currently non-compliant with Nasdaq Listing Rule 5605(c)(2)(A), which mandates a minimum of three independent directors on the Audit Committee.
- Equity Issuance: On August 6, 2026, the Company issued 619,000 restricted shares of Class B common stock to employees under the 2024 Restricted Stock Plan. These shares vest in full on September 30, 2030, subject to continued service.
Guidance, Outlook, and Risks
- Cure Period: The Company intends to utilize the Nasdaq cure period to regain compliance. The deadline is the earlier of the next annual meeting of stockholders or July 22, 2027.
- Management Action: The Board will begin identifying and selecting a new independent director as soon as practicable to satisfy listing requirements.
- Risks: Forward-looking statements regarding the appointment of a new director involve uncertainties. Failure to identify and retain a qualified independent director within the cure period could result in delisting.
Investor Verification Checklist
- Verify the timeline for the appointment of a new independent director to ensure compliance before the July 22, 2027, deadline.
- Review the impact of the 619,000 unregistered Class B share issuance on total outstanding equity and potential dilution.
- Monitor future filings for confirmation of the new director's appointment and the restoration of full Nasdaq compliance.
- Check the Company's most recent Form 10-K and 10-Q for broader risk factors related to corporate governance and board composition.